Your account is not claimed yet. You can sign up with ORCID to claim your account.

Nikolaos Biris

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Spinal Cord Injury

Molecular Dynamics

Top Venues

Science (New York, N.Y.)

Nature communications

The Journal of pharmacology and experimental therapeutics

HarkerBio

This page only lists publications with an associated author ORCID identifier.

Affiliation History

HarkerBio Mar 1o 2017

United States

Principal Project Scientist

Publications

Vahe Bedian, Nikolaos Biris, Charles Omer, Jou-Ku Chung, James Fuller, Rafif Dagher, Sachin Chandran, Peter Harwin, Tomas Kiselak, Jonathan Violin, Andrew Nichols, Pradeep Bista
STAR-0215 is a Novel, Long-Acting Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Potential Treatment of Hereditary Angioedema . The Journal of pharmacology and experimental therapeutics (2023)
Emmanouil Zacharioudakis, Bogos Agianian, Vasantha Kumar Mv, Nikolaos Biris, Thomas P Garner, Inna Rabinovich-Nikitin, Amanda T Ouchida, Victoria Margulets, Lars Ulrik Nordstrøm, Joel S Riley, Igor Dolgalev, Yun Chen, Andre J H Wittig, Ryan Pekson, Chris Mathew, Peter Wei, Aristotelis Tsirigos, Stephen W G Tait, Lorrie A Kirshenbaum, Richard N Kitsis, Evripidis Gavathiotis
Modulating mitofusins to control mitochondrial function and signaling. Nature communications 13 (1) (2022)
Agostinho G Rocha, Antonietta Franco, Andrzej M Krezel, Jeanne M Rumsey, Justin M Alberti, William C Knight, Nikolaos Biris, Emmanouil Zacharioudakis, James W Janetka, Robert H Baloh, Richard N Kitsis, Daria-Mochly Rosen, R Reid Townsend, Evripidis Gavathiotis, Gerald W Dorn
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science (New York, N.Y.) 360 (6386) (2018)